Publications
5600 Results
- Journal / Conference
- Blood Cancer Journal, Jul 6;8(7):67
- Year
- 2018
- Research Committee(s)
- Cancer Survivorship and Myeloma
- PMID
- PMID29980678
- PMC
- PMC6035273
- Study Number(s)
- S0204, S0232, SWOG-9321
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials
- Journal / Conference
- AcademyHealth Annual Research Meeting (June 23-26, 2018, Seattle, WA), poster #B-335
- Year
- 2018
- Research Committee(s)
- Breast, Cancer Care Delivery, Gastrointestinal, Genitourinary, Gynecologic, Leukemia, Lung, Lymphoma, Melanoma, and Myeloma
- Study Number(s)
- S0003, S0008, S0012, S0106, S0124, S0200, S0205, S0226, S0232, S0421, SWOG-8501 (INT-0051), SWOG-8612, SWOG-8691 (INT-0073), SWOG-8692 (INT-0075), SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891), SWOG-8794, SWOG-8795 (INT-0094) (EST-1888), SWOG-8812, SWOG-8814, SWOG-8894 (INT-0105) (EST-2889), SWOG-8949, SWOG-9028, SWOG-9031, SWOG-9032, SWOG-9133, SWOG-9210, SWOG-9308, SWOG-9313, SWOG-9321, SWOG-9333, SWOG-9346, SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415), SWOG-9420, SWOG-9509, S9623, S9701, S9916
Value of Anti-Cancer Drugs in SWOG Phase III Clinical Trials: Evidence from Multiple Evaluation Mechanisms
- Journal / Conference
- Society for Clinical Trials Annual Meeting (May 20-23 2018, Portland, OR), oral presentation
- Year
- 2018
- Research Committee(s)
- Breast, Gastrointestinal, Genitourinary, Leukemia, Lung, Lymphoma, Myeloma, and Sarcoma
- Study Number(s)
- S0003, S0012, S0016, S0033, S0106, S0221, S0226, S0232, S0307, S0421, S0500, SWOG-8516 (INT-0067), SWOG-8600, SWOG-8809, SWOG-8814, SWOG-8894 (INT-0105) (EST-2889), SWOG-8897, SWOG-8905, SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195), SWOG-9031, SWOG-9125, SWOG-9210, SWOG-9240, SWOG-9304 (INT-0144), SWOG-9308, SWOG-9313, SWOG-9321, SWOG-9333, SWOG-9346
Survival by Hispanic Ethnicity Among Cancer Patients participating in SWOG Clinical Trials
- Journal / Conference
- Clinical Cancer Research Oct 1;24(19):4734-4744
- Year
- 2018
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID29871907
- PMC
- PMC6168379
- Study Number(s)
- CTSU/C80405
Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension
- Journal / Conference
- JAMA Oncology Sep 1;4(9):1197-1198; Jun 14 [Epub ahead of print]
- Year
- 2018
- Research Committee(s)
- Lung
- PMID
- PMID29902311
- PMC
- n/a - commentary
- Study Number(s)
- S1400B, S1400C, S1400D
In Search of an Oncogene Driver for Squamous Lung Cancer [Invited Commentary]
- Journal / Conference
- Blood Sep 6;132(10):1013-1021; Jul 26 [Epub ahead of print]
- Year
- 2018
- Research Committee(s)
- Lymphoma
- PMID
- PMID30049811
- PMC
- PMC6128083
CALBG 50604: Risk-Adapted Treatment of Non-Bulky Early Stage Hodgkin Lymphoma based on Interim PET
- Journal / Conference
- Obesity Oct;26(10):1539-1549
- Year
- 2018
- Research Committee(s)
- Cancer Survivorship
- PMID
- PMID30272836
- PMC
- PMC6611675
- Study Number(s)
- S1008
Phase II Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention in Breast and Colorectal Cancer Survivors (SWOG S1008)
- Journal / Conference
- WCLC IASCLC Annual Meeting (Sept 23-26, 2018, Toronto CAN), oral
- Year
- 2018
- Research Committee(s)
- Lung
- Study Number(s)
- S0424
Case-Series Study in Ever- and Never-Smoking Females and Males with NSCLC: Exposures, Tumor Factors, Biology and Survival (SWOG S0424)
- Journal / Conference
- WCLC IASCLC Annual Meeting (Sept 23-26, 2018, Toronto CAN), oral
- Year
- 2018
- Research Committee(s)
- Lung
- Study Number(s)
- S1403
Afatinib with or without cetuximab for EGFR-mutant non-small cell lung cancer: Safety and efficacy results from SWOG S1403
- Journal / Conference
- Annals of Oncology Feb 1;29(2):289-290
- Year
- 2018
- Research Committee(s)
- Genitourinary
- PMID
- PMID29236938
- PMC
- PMC5834095